Sharma Neera, Dutta Deep, Sharma Lokesh Kumar
Dr. Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, Department of Biochemistry, New Delhi, India.
Venkateshwar Hospital, Clinic of Diabetes, Endocrinology and Metabolic Disorder, New Delhi, India.
J Clin Res Pediatr Endocrinol. 2017 Dec 15;9(4):350-354. doi: 10.4274/jcrpe.4536. Epub 2017 May 22.
Prevalence of hyperprolactinemia in children with subclinical hypothyroidism (ScH) is not known. This study aimed to determine the occurrence and predictors of hyperprolactinemia in euthyroid children and in children with ScH and overt primary hypothyroidism (OPH). Serum prolactin levels were estimated in consecutive children <18 years of age undergoing thyroid function evaluation and diagnosed to have normal thyroid function, ScH, or OPH. Children with pituitary adenomas, secondary hypothyroidism, multiple pituitary hormone deficiency, comorbid states, and drug-induced hyperprolactinemia were excluded. From the initially screened 791 children, hormonal data from 602 children who fulfilled all criteria were analyzed. Seventy-one (11.79%) of these had ScH, and 33 (5.48%) had OPH. Occurrence of hyperprolactinemia was highest in the OPH group (51.51%), followed by ScH (30.98%) and euthyroid children (4.41%) (p<0.001). Median (25-75 percentiles) levels for prolactin in euthyroid, ScH, and OPH children were 13.3 (9.4-17.95), 19.15 (15.97-30.12), and 28.86 (17.05-51.9) ng/mL, respectively (p<0.001). In children, prolactin levels were comparable in males and females. An age-related increase in serum prolactin was noted in euthyroid children, which was statistically significant in post-pubertal (16-18 years) children. Area under the curve for thyroid stimulating hormone (TSH) in predicting hyperprolactinemia in children was 0.758 (95% confidence interval: 0.673-0.829; p<0.001). TSH ≥4.00 mIU/L had a sensitivity of 69.4% and specificity of 77.6% in detecting hyperprolactinemia. Hyperprolactinemia is common in children with ScH and OPH. TSH ≥4.00 mIU/L has a good sensitivity and specificity in predicting hyperprolactinemia in children. More studies are needed to establish if hyperprolactinemia should be an indication for treating ScH in children.
亚临床甲状腺功能减退(ScH)患儿高催乳素血症的患病率尚不清楚。本研究旨在确定甲状腺功能正常的儿童、ScH患儿和显性原发性甲状腺功能减退(OPH)患儿中高催乳素血症的发生率及预测因素。对连续接受甲状腺功能评估且诊断为甲状腺功能正常、ScH或OPH的18岁以下儿童测定血清催乳素水平。排除患有垂体腺瘤、继发性甲状腺功能减退、多种垂体激素缺乏、合并症和药物性高催乳素血症的儿童。对最初筛查的791名儿童中符合所有标准的602名儿童的激素数据进行分析。其中71名(11.79%)患有ScH,33名(5.48%)患有OPH。高催乳素血症的发生率在OPH组最高(51.51%),其次是ScH组(30.98%)和甲状腺功能正常的儿童(4.41%)(p<0.001)。甲状腺功能正常、ScH和OPH儿童的催乳素中位数(第25-75百分位数)水平分别为13.3(9.4-17.95)、19.15(15.97-30.12)和28.86(17.05-51.9)ng/mL(p<0.001)。儿童中,男性和女性的催乳素水平相当。甲状腺功能正常的儿童血清催乳素随年龄增加,在青春期后(16-18岁)儿童中具有统计学意义。甲状腺刺激激素(TSH)预测儿童高催乳素血症的曲线下面积为0.758(95%置信区间:0.673-0.829;p<0.001)。TSH≥4.00 mIU/L检测高催乳素血症的灵敏度为69.4%,特异度为77.6%。高催乳素血症在ScH和OPH患儿中很常见。TSH≥4.00 mIU/L在预测儿童高催乳素血症方面具有良好的灵敏度和特异度。需要更多研究来确定高催乳素血症是否应作为儿童ScH治疗的指征。